Related Experiment Video
Updated: Aug 1, 2026

06:36
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
7.1K
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms
Dániel Pukoli1, László Vécsei2,3
1Department of Neurology, Esztergomi Vaszary Kolos Hospital, 2500 Esztergom, Hungary.
International Journal of Molecular Sciences
|August 26, 2023
Summary
Multiple sclerosis involves chronic inflammation and neurodegeneration, leading to smoldering lesions. Understanding pathobiochemical markers in these lesions is key to insights into disease progression and clinical classification.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) is a chronic CNS disease characterized by inflammation, demyelination, and neurodegeneration.
- Immune cell infiltration leads to persistent macrophage/microglia activation, causing demyelination and neurodegeneration.
- Chronic inflammation underlies smoldering lesions, associated with continuous demyelination and poor prognosis.
Purpose of the Study:
- To review the pathobiochemical markers and mechanisms driving neurodegeneration in MS smoldering lesions.
- To elucidate the relationship between these markers and clinical disease progression.
- To understand the link between MS clinical classification and pathomechanisms.
Main Methods:
- Review of existing literature on MS pathogenesis.
- Analysis of pathobiochemical factors within smoldering lesions.
- Discussion of immune mediators, oxidative stress, mitochondrial damage, hypoxia, iron, and glutamate.
Main Results:
- Smoldering lesions create a toxic environment contributing to neurodegeneration.
- Oxidative stress, mitochondrial dysfunction, hypoxia, iron, and glutamate are implicated in cell death.
- These factors, alone or combined, drive neuronal, axonal, and glial cell death.
Conclusions:
- Pathobiochemical markers in smoldering lesions are crucial for neuroinflammation and neurodegeneration in MS.
- Understanding these markers provides insight into MS progression and clinical subtypes.
- Targeting these mechanisms may offer therapeutic strategies for progressive MS.
Keywords:
glutamate excitotoxicitylymphocytemicrogliamitochondrial dysfunctionmultiple sclerosisneurodegenerationneuroinflammationoxidative stressslowly expanding lesionsmouldering lesionMore Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

